Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes After Implantation of the AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (MIOL) in the Dominant Eye and Randomization of the AcrySof® IQ ReSTOR® +2.5 D or +3.0 D MIOL in the Fellow Eye

NCT01684007 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT01684007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01684007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes After Implantation of the AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (MIOL) in the Dominant Eye and Randomization of the AcrySof® IQ ReSTOR® +2.5 D or +3.0 D MIOL in the Fellow Eye
Lead sponsor
Alcon Research
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
August 31, 2013
Enrollment
112 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cataracts